Injective (INJ) is currently priced at $3.01, reflecting a slight decline of 1.31% over the last 24 hours. The price action has been relatively stable, with a daily range of 0.19% between a low of $3.00 and a high of $3.19.

The trading volume stands at approximately $50.42 million, representing 16.76% of the market cap, indicating active market participation. However, the price has experienced a significant 7-day decline of 15.38%, with longer-term trends showing a 30-day decrease of 25.76%, suggesting ongoing bearish sentiment.

Technical indicators show that the hourly moving averages are all positioned above the current price, with the 8 SMA at $3.05 and the 21 SMA at $3.09, signaling resistance levels. The 1-hour RSI at 30 indicates an oversold condition, while the 7-day RSI at 45 suggests a potential for a rebound if buying pressure increases.

Despite the current negative price action, the asset remains significantly below its all-time high of $52.62 reached in March 2024, indicating considerable room for recovery. Given the historical volatility and the recent price trends, the potential for a rebound exists, but the market remains cautious.

Based on the current analysis, a Hold rating is recommended. The oversold conditions may present a short-term buying opportunity, yet the persistent downward trend over the past month warrants caution before entering new positions.